Why Did Peptide Sciences Shut Down? Timeline, FDA Pressure, and What It Means for the Industry
Peptide Sciences, the largest gray-market research peptide vendor in the U.S., voluntarily shut down on March 6, 2026. A breakdown of the FDA enforcement actions, pharmaceutical lawsuits, and new legislation that led to the closure.
Read Full ArticleAll News
FTC Crackdown on Peptide Advertising: Social Media, Influencer Marketing, and Compliance
How the FTC is targeting peptide advertising on social media and through influencers, and what companies need to do to stay compliant.
How to Spot Fake Peptides: Legal Risks of Counterfeit Products
Counterfeit and mislabeled peptides flood the market, posing serious health and legal risks. Learn how to identify fake peptides, understand testing methods, and know your legal rights when dealing with fraudulent products.
UK Peptide Laws: New MHRA Rules & Import Guide
UK Peptide Laws: MHRA Regulations and Import Rules 2024 - An In-Depth Analysis Overview of the Regulatory Action The United Kingdom's regulatory landscape for peptides is governed primarily by the Medicines and Healthcare products Regulatory Agency (MHRA).
Canada Peptide Laws: Regulations & Risks
Overview of Health Canada's Peptide Regulations Health Canada's regulation of peptides involves a complex interplay of drug scheduling, prescription requirements, importation rules, and provincial variations.
Criminal Prosecutions in the Peptide Industry: Recent Cases
The peptide industry, once a niche segment within the broader pharmaceutical landscape, has seen exponential growth over recent years.
FDA Import Alerts Affecting Peptide Research Chemicals
The landscape of peptide research chemicals is evolving rapidly, driven by scientific advancements and increasing interest in their potential therapeutic applications.
Recent DOJ Actions Against Illegal Peptide Distributors
The peptide industry, a burgeoning sector due to the potential therapeutic benefits of peptides in treating various diseases, finds itself under scrutiny as the U.S. Department of Justice (DOJ) intensifies its actions against illegal distributors.
Warning Letter Analysis: Common Violations by Peptide Companies
In the fast-evolving landscape of pharmaceuticals, peptides have emerged as a crucial segment due to their potential in treating a wide range of conditions.
Customs Seizures of Imported Peptides: Legal Implications
The importation of peptides into the United States has seen a marked increase, driven by the burgeoning interest in their potential therapeutic applications. However, this trend has also led to a rise in customs seizures of these substances.